Navigation Links
Study to look at early surgery to treat epilepsy

Epilepsy is a disorder affecting more than 2 million people worldwide and is caused by abnormal surges in the electrical circuits of the brain that result in seizures. More than half of those with epilepsy can live seizure-free by taking medications.
But now a new study is under way to determine just how effective surgery is compared to drug therapy when treating those with temporal lobe epilepsy, //the most common form of the disorder. Typically, about 80 percent of people who have this type of epilepsy, will be completely free of all seizures after the surgery say doctors.

Sponsored by the National Institutes of Health, the trial study will offer half of the 200 participants brain surgery, while the remaining 100 will continue on medications. Both groups then will be monitored for two years to determine which treatment is more effective at eliminating seizures and improving quality of life.

Participants will be people who have had seizures for no more than 2 years and are unable to bring them under control with medications.

Most people spend more than a decade trying different drugs before considering surgery. For some patients , the surgery provided a way to get their epilepsy under control. Not all patients respond as well to the surgery, and doctors warn the procedure is not for everyone.

"There is approximately a 1 percent risk of significant disability due to stroke, bleeding or other complications when we look at a large series of patients," say doctors.
'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Its Never Too Late to Stop Smoking,Study Finds
9. New Technique to Study Infants Brain.
10. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
11. Study On Self Measurement Of Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: